A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer

Author： Perez-Marrero Ramon Tyler Robert C

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.2, 2004-02, pp. : 447-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leuprolide Acetate Release Study from #947;-Irradiated PLGA-based In Situ Forming System

Current Drug Delivery, Vol. 14, Iss. 8, 2017-12 ,pp. : 1170-1177

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate delivery of LHRH analogue for the treatment of prostate cancer

By Tomar Priti

Pharmaceutical Development and Technology, Vol. 18, Iss. 3, 2013-06 ,pp. : 645-652

Informa Healthcare

Access to resources Recommend Favorite

Abiraterone acetate for the treatment of prostate cancer

By Ryan Charles J Cheng Michael L

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 91-96

Informa Healthcare

Access to resources Recommend Favorite

An extended-release formulation of desferrioxamine for subcutaneous administration

By Toliyat Tayebeh Jorjani Masomeh Khorasanirad Zeinab

Drug Delivery, Vol. 16, Iss. 7, 2009-10 ,pp. : 416-421

Informa Healthcare

Access to resources Recommend Favorite

Controlled Release Tacrine Delivery System for the Treatment of Alzheimer's Disease

By Yang Qing Williams Douglas Owusu-Ababio Godfried Ebube Nkere K. Habib Muhammad J.

Drug Delivery, Vol. 8, Iss. 2, 2001-04 ,pp. : 93-98

Informa Healthcare

Access to resources Recommend Favorite